Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$574M |
| 2 |
TotalEnergies
TTE
|
+$573M |
| 3 |
MDLN
Medline Inc
MDLN
|
+$446M |
| 4 |
Micron Technology
MU
|
+$389M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$387M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.11B |
| 3 |
Mastercard
MA
|
+$557M |
| 4 |
Autodesk
ADSK
|
+$554M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$490M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.83% |
| 2 | Healthcare | 19.29% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
The Bancorp
TBBK
$2.81B
| $61.6M | 0.03% |
912,067
-262,192
| -22% | -$18.1M |
|
377
Kirby Corp
KEX
$7.02B
| $61.5M | 0.03% |
558,300
-27,074
| -5% | -$2.75M |
|
378
Intel
INTC
$426B
| $61.5M | 0.03% |
1,666,719
+7,729
| +0.5% | +$292K |
|
|
ACLX
379
DELISTED
Arcellx
ACLX
| $60M | 0.03% |
919,578
-94,343
| -9% | -$7.53M |
|
380
Spyre Therapeutics
SYRE
$8.59B
| $59.9M | 0.03% |
1,829,009
+1,816,009
| +13,969% | +$47.5M |
|
381
Vanguard FTSE Emerging Markets ETF
VWO
$118B
| $59.1M | 0.03% |
1,100,122
-14,159
| -1% | -$769K |
|
382
Janus Henderson AAA CLO ETF
JAAA
$29.1B
| $59M | 0.03% |
1,166,319
-573,210
| -33% | -$29M |
|
383
Enanta Pharmaceuticals
ENTA
$367M
| $58.8M | 0.03% |
3,729,659
+1,782,745
| +92% | +$22.6M |
|
384
Halozyme
HALO
$9.88B
| $58.1M | 0.03% |
863,956
-94,073
| -10% | -$6.33M |
|
385
Medpace
MEDP
$16.5B
| $58M | 0.03% |
103,245
+9,961
| +11% | +$5.65M |
|
386
Travelers Companies
TRV
$81.7B
| $58M | 0.03% |
199,805
-3,820
| -2% | -$1.08M |
|
387
BioCryst Pharmaceuticals
BCRX
$2.44B
| $57.8M | 0.03% |
7,404,386
+7,310,745
| +7,807% | +$52.9M |
|
388
ExxonMobil
XOM
$648B
| $57.5M | 0.03% |
478,018
+72,085
| +18% | +$8.36M |
|
389
American Homes 4 Rent
AMH
$12.1B
| $56.2M | 0.03% |
1,749,424
-47,767
| -3% | -$1.53M |
|
390
Littelfuse
LFUS
$10.4B
| $55.4M | 0.02% |
219,039
-1,845
| -0.8% | -$470K |
|
391
Ceco Environmental
CECO
$3.54B
| $55.2M | 0.02% |
922,000
+1,898
| +0.2% | +$102K |
|
392
Lexeo Therapeutics
LXEO
$340M
| $54.7M | 0.02% |
5,509,635
-595,892
| -10% | -$5.44M |
|
|
EXE
393
Expand Energy Corp
EXE
$22.1B
| $54.4M | 0.02% |
492,758
+20,066
| +4% | +$2.23M |
|
394
Alnylam Pharmaceuticals
ALNY
$38.3B
| $54.3M | 0.02% |
136,425
+570
| +0.4% | +$252K |
|
395
Franklin FTSE United Kingdom ETF
FLGB
$901M
| $54.2M | 0.02% |
1,606,862
-17,759
| -1% | -$584K |
|
396
Krystal Biotech
KRYS
$10.7B
| $54.1M | 0.02% |
219,440
+209,369
| +2,079% | +$44.1M |
|
397
Advanced Micro Devices
AMD
$716B
| $54M | 0.02% |
252,552
+1,622
| +0.6% | +$364K |
|
398
Amylyx Pharmaceuticals
AMLX
$2.19B
| $54M | 0.02% |
4,465,872
+1,929,639
| +76% | +$26.2M |
|
399
EyePoint Inc
EYPT
$1.02B
| $53.7M | 0.02% |
+2,937,729
| New | +$41.6M |
|
400
Crane Co
CR
$12B
| $53.5M | 0.02% |
290,184
+52,419
| +22% | +$9.72M |
|
Similar funds
Janus Henderson Group's Q4 2025 Portfolio in Review
As of Q4 2025, Janus Henderson Group held 2,496 positions worth $223B, up 1.9% from $219B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Janus Henderson Group's Q4 2025 filing shows 100 new, 812 increased, 609 reduced and 90 closed positions. Its largest new stake was TotalEnergies: 9,061,622 shares worth $591M. The largest sale was Meta Platforms (Facebook), an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2025 buy was TotalEnergies: 9,061,622 shares worth $591M.
- Janus Henderson Group added most to Workday in Q4 2025, an estimated $574M increase.
- Janus Henderson Group's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $1.19B.
- Janus Henderson Group fully exited Akero Therapeutics in Q4 2025, selling an estimated $298M.
- Janus Henderson Group's ten largest holdings make up 33% of its $223B portfolio in Q4 2025.
- Janus Henderson Group opened 100 new positions and closed 90 in Q4 2025.
- Janus Henderson Group's portfolio value rose 1.9% quarter-over-quarter to $223B.
Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.